Australia-China Bioinnovation Roundtable 2026
2026 Australia–China BioInnovation Roundtable
Going Global, Together
An official satellite event of AusBiotech's Australia's Biggest Week in Biotech
Principal partner: WuXi AppTec
China's biotech companies have gone global fast — record out-licensing volumes and direct deals with the world's largest pharmaceutical firms. Australia has the science, the trials and the incentives, but fewer companies that have made the jump.
Each side has something the other wants. That's the conversation.
Our third Roundtable, held on day one of Australia's Biggest Week in Biotech — a few minutes from the convention centre, while the industry is already in town. A Shanghai venue runs alongside, so the China side speaks for itself rather than being reported secondhand.
The 2025 edition brought together 100+ delegates across Melbourne and Shanghai, with 43,000 joining online. This one stays deliberately small: half a day, capped at 80, built around discussion rather than presentations.
Confirmed speakers:
Zeyang Tang, General Manager, Biotech, Shanghai Guotou Xiandao Fund
Tao Ru, Managing Director – Biotech, Shanghai Guotou Xiandao Fund
Jing Jin, Executive Director, WuXi AppTec Laboratory Testing Division - DMPK Services, WuXi AppTec
Dr Fugang (Frank) Li, Executive Director, In Vivo Pharmacology Unit, WuXi Biology, WuXi AppTec
Dr Zhou Zhou, Head of Asia-Pacific Sales & Marketing in Testing, WuXi AppTec
Dr Tim Oldham, CEO and Managing Director, AdAlta Ltd
Stuart Dignam, CEO, AUScelerate
Dr Yue (Olivia) Geng, Partner, Altea Investments
Dr Ben Phillis, Head of Investment Fund, UniQuest Ltd.
Riddick Jie, Director, Aeterna Health
Alan Cui, Managing Partner, Boson Ventures
Raul Chavez, Investment Principal, Boson Ventures
The afternoon
12:30 Registration and light lunch
13:00 Welcome and opening remarks
Alan Cui, Managing Partner, Boson Ventures · Dr Zhou Zhou, Head of Asia-Pacific Sales & Marketing in Testing, WuXi AppTec · Local Member of Parliament
13:15 The State of Australia's BioInnovation Ecosystem
Where Australian biotech stands in 2026, and the challenges it faces. Stuart Dignam, Chief Executive Officer, AUScelerate.
13:35 The China Perspective
The Chinese ecosystem and a first-hand account of how it has developed. Zeyang Tang, General Manager, Biotech, Shanghai Guotou Xiandao Fund
13:55 Panel: Collaboration Beyond Borders
How each ecosystem's push to go global is reshaping the way it operates, and where the two paths cross and reinforce one another. Moderated discussion, then open floor.
Dr Tim Oldham, Chief Executive Officer, AdAlta · Riddick Jie, Director, Aeterna Health · and further panellists
14:55 Afternoon tea
15:20 Spotlight and Technical Clinic
A keynote from Jin Jing, Executive Director, DMPK at WuXi AppTec, followed by a panel on what cross-border development support looks like in practice — and an open clinic covering R&D tax incentive eligibility, timelines and cost, answered by an Australian tax specialist and companies who have been through it. With Frank Li, Executive Director, In Vivo Pharmacology, WuXi AppTec.
16:00 Investor Panel
The capital view from both markets. Moderated by Raul Chavez, Investment Principal, Boson Ventures, with Ru Tao, Managing Director, Shanghai Guotou Xiandao Fund and Ben Phillis, Head of Investment Fund, UniQuest.
16:50 Roundtable: Capital, Partnering and Going Global
Facilitated, no stage. Australian founders seeking Chinese capital; Chinese companies landing in Australia; what makes a cross-border partnership work, and what makes one fail.
17:20 Closing remarks
Alan Cui, Managing Partner, Boson Ventures
17:30–18:30 Networking drinks reception
Further speakers announced shortly. Programme subject to minor change.
Who's in the room
Biotech founders and heads of development, from pre-clinical through Phase II. Translational research leaders and commercialisation offices. R&D and partnering teams from Australian pharma. Life sciences investors and cross-border funds. Chinese biotech and pharma delegates attending Australia's Biggest Week in Biotech. R&D tax and IP advisers, CROs and trial networks.
AusBiotech's Australia's Biggest Week in Biotech brings together the biotechnology and life sciences community for a week of sector events, collaboration and connection on the Gold Coast from 19–23 October 2026. The 2026 Australia–China BioInnovation Roundtable is proud to be an official satellite event partner.